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ABSTRACT
This review analyzes the relationship between microvesicles and reactive oxygen species (ROS).
This relationship is bidirectional; on the one hand, the number and content of microvesicles
produced by the cells are affected by oxidative stress conditions; on the other hand, microvesicles
can directly and/or indirectly modify the ROS content in the extra- as well as the intracellular
compartments. In this regard, microvesicles contain a pro-oxidant or antioxidant machinery that
may produce or scavenge ROS: direct effect. This mechanism is especially suitable for eliminating
ROS in the extracellular compartment. Endothelial microvesicles, in particular, contain a specific
and well-developed antioxidant machinery. On the other hand, the molecules included in micro-
vesicles can modify (activate or inhibit) ROS metabolism in their target cells: indirect effect. This
can be achieved by the incorporation into the cells of ROS metabolic enzymes included in the
microvesicles, or by the regulation of signaling pathways involved in ROS metabolism. Proteins,
as well as miRNAs, are involved in this last effect.
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Microvesicles (MVs)
Extracellular vesicles are membranous subcellular
structures produced by the cells; they are located in
the extracellular space and are especially abundant in
blood, urine, milk, saliva, semen, synovial or cerebrosp-
inal fluid, among other liquids. According to their
origin, size and biochemical composition, they are
usually classified into three categories: exosomes,
microvesicles (MVs) (also microparticles or ectosomes)
and apoptotic bodies. The exosomes are 40–120 nm
vesicles included in multi-vesicular bodies which are
released to the extracellular space after fusion of these
multi-vesicular bodies with the plasma membrane.
MVs arise through budding and fission of the plasma
membrane and are larger (50–1000 nm) than the exo-
somes [1]. Both types of vesicles are produced by all
cells and have different functions [2]; however, it is not
always easy to distinguish them [3,4]. Apoptotic bodies
are the largest extracellular vesicles (1–5 um) and are
formed during the late stages of apoptosis [1].
MVs represent an extraordinarily heterogeneous popu-
lation of extracellular vesicles [5]. Not only are they hetero-
geneous in size (ranging from 0.1 to 1.5 μm) but also in
their origin, biochemical content and, obviously, function.
Blood MVs, in particular, are a paradigm of this hetero-
geneity; they can be secreted by erythrocytes, leucocytes,
platelets or endothelial cells, each one with a different con-
tent and function [6].Obtaining samples containinghomo-
geneous populations of MVs is one of the main
methodological challenges for the future.
The main function ascribed to MVs is a role in inter-
cellular communication; however, many specific functions
have also been associated with them depending on their
cellular origin. Cell adhesion and migration [7,8], waste
management [9], vascular function [10], coagulation [11],
reticulocyte maturation [12], modulation of the immune
response [13], fertilization [14], embryonic development
[15], bone calcification [16] and tissue repair [17,18] are
activities where MVs, as well as exosomes, have been
involved. Moreover, an increase of MV production has
been associated with pathological states [19,20], tumor
growth, metastasis and angiogenesis [21,22]. They have
also been postulated to be biomarkers and/or therapeutic
targets [23], especially those derived from mesenchymal
stem cells [24]. In fact, a significant therapeutic effect of
mesenchymal stem cell-derived extracellular vesicles is the
reduction of oxidative stress [25].
Oxidative stress and reactiveoxygen species (ROS)
Under normal conditions, ROS production and ROS
elimination are balanced; however, oxidative stress
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represents an imbalance due to an increase of ROS
[26]. Thus, ROS production and ROS detoxification
must be continuously adapted in order to respond to
changes and alterations that occur during the cell´s
lifespan. The ROS increase has been associated with
stress conditions and has been shown to be the causal
agent of different pathologies such as neurodegenera-
tive disorders (Alzheimer´s disease, Parkinson´s dis-
ease and amyotrophic lateral sclerosis) [27,28],
cardiovascular diseases [29,30] and carcinogenesis
[31]. In general, ROS production increases with ageing
[32], although it has also been proposed to be an
adaptive response [33] that may be physiologically
modified by age, sex (menopause), tumour growth or
stress conditions.
ROS are a group of molecules and free radicals
(atoms or molecules with an unpaired valence electron)
derived from oxygen. They can be of exogenous (xeno-
biotics, radiation, pollutants …) or endogenous origin.
The latter is a result of the cell’s own metabolism:
mitochondrial respiration (especially ubiquinone and
complex III of the electron transport chain) [34,35],
oxidoreductase activities, metal-catalyzed oxidation
and NADPH oxidase activity, especially in the respira-
tory burst of phagocytes [36].
ROS have numerous toxic and harmful effects due
to their high reactivity. They are involved in different
pathologies and, hence, cells have developed
a complete antioxidant machinery for ROS scavenging
(Figure 1). This antioxidant system includes enzymatic
components, such as superoxide dismutases, catalase,
peroxidases, reductases, and non-enzymatic compo-
nents, such as vitamins C, E and A, glutathione, per-
oxiredoxins, thioredoxins, etc. It also includes
enzymatic activities such as heme-oxygenase or cate-
chol-O-methyltransferase directed at preventing ROS
formation. Because the primary source of endogenous
ROS is the intracellular compartment (mitochondria,
peroxisomes and reticulum), cells have a stronger anti-
oxidant machinery than the extracellular compartment.
ROS have two faces: good and bad. The first
involves low ROS levels whereas the second involves
high ROS levels [37]. It is well known that ROS are
associated with a high number of different pathologies
(previous paragraph) because they cause damage to
biomolecules (lipids, proteins and DNA) and subcellu-
lar structures; however, ROS are also involved in main-
taining physiological conditions [38,39]. Reactive
nitrogen species (RNS) such as nitric oxide and nitro-
gen dioxide, among others, can also cause oxidative
damage and act as components of intracellular signal-
ing cascades [40]. In fact, the possibility that MVs act
as scavengers of nitric oxide has also been proposed
[41]. Nonetheless, the relationship between MVs and
RNS is not considered in this review.
Under physiological conditions, ROS are involved in
cell signaling, regulating a wide variety of functions
[39]. These include activation of gene transcription
Figure 1. Diagram showing the two main ROS (superoxide radical, O2
−, and hydrogen peroxide, H2O2) and the more essential
enzymes and peptides of the antioxidant machinery. CAT: catalase; GPX: glutathione peroxidase; GSH and GSSH: reduced and
oxidized glutathione; GSR: glutathione reductase; GST: glutathione S-transferase (detoxify xenobiotics); HMOX: heme oxygenase;
PRDX: peroxiredoxin; SOD: superoxide dismutase; TRX: thioredoxin; TRXR: thioredoxin reductase. Other important ROS not included
in the diagram are: hydroxyl (OH−), peroxyl (RO2
−), alkoxyl (RO−) and hydroperoxyl (HO2
−) radicals, as well as ozone (O3) and singlet
oxygen (1O2) as non-radical ROS. Note that the fuel that nourishes the antioxidant machinery is NADPH.
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(directly activating transcription factors, or indirectly
activating MAPK cascades) [42,43], regulation of intra-
cellular signaling pathways [44], modulation of calcium
signaling [45], apoptosis [46,47], autophagy [48,49],
cellular growth [50], and embryonic development as
a consequence of their role in proliferation, differentia-
tion, and apoptosis [51]. ROS are also involved in the
destruction of pathogens [9] and in inflammatory pro-
cesses [52,53], blood pressure control [54] and
response to physical exercise [55].
ROS are involved in a high number of essential
physiological processes, but while low ROS levels are
related with physiological conditions, high ROS levels
and the subsequent oxidative stress are generally asso-
ciated with pathological conditions [56]. Therefore,
ROS levels have to be finely regulated in the intracel-
lular as well as the extracellular compartment. The
biochemical, physiological and structural differences
of both compartments make it impossible for them to
have identical or similar mechanisms for regulating
these levels. The differential distribution and expres-
sion of SOD subtypes in these two compartments is
a good example of this. SOD1 is located in the cytosol,
SOD2 in mitochondria and SOD3 in the extracellular
compartment. To maintain proper ROS levels, the
activity of these enzymes has to be finely regulated, as
can be demonstrated by the fact that a single amino
acid substitution in human SOD1 is associated with
familial amyotrophic lateral sclerosis whereas the
knockout of the SOD2 gene is related to lethal cardio-
myopathy in mice [57]. The loss of SOD3 expression
has also been associated with a pancreatic ductal ade-
nocarcinoma [58]. This differential system of ROS
elimination among intra- and extracellular compart-
ments raises a special interest in analyzing the relation-
ship between extracellular vesicles and the adjustment
of ROS levels in the extracellular space.
Microvesicles and ROS
MVs and ROS are closely interrelated, not only
because MVs can produce or detoxify ROS, but also
because ROS are involved in the production of MVs.
Pro-oxidant conditions seem to induce extracellular
vesicle release [59]; in fact, NADPH oxidase and
nitric oxide synthase-2 (NOS-2) inhibitors inhibit
the production of MVs in neutrophils [60]. It is
worthy to point out that tumoural [61] and senescent
cells [62] also produce a higher number of MVs, and
both types have altered redox balances with elevated
ROS levels [63,64]). MVs can also serve as an alter-
native mechanism to remove oxidized proteins after
oxidative stress, enabling their use as biomarkers for
oxidative stress [65].
The effect of MVs on ROS depends on both the
conditions of the cell that originates these vesicles and
those of the target cell, as well as the environmental
conditions. In fact, oxidative conditions affect the
content of MVs [65]; for example, MVs of ischemic
muscle [66] or those produced after a high-fat diet
[67] produce more ROS than controls. In addition,
endothelial-derived MVs obtained after starvation or
apoptotic stress have different effects on endothelial
cells after hypoxic stress: the former show beneficial
effects whereas the latter exhibit detrimental effects
[68]. In endothelial cells, specifically human umbilical
vein endothelial cells (HUVEC), high glucose condi-
tions have been shown to induce a three-fold increase
in MV production, with differences in the molecular
composition of these vesicles [69], whereas neutro-
phils produce diverse MVs in response to different
activators [70]. Moreover, direct and indirect effects
can be carried out by the same MVs: T-lymphocyte-
derived MVs exert a potentially beneficial effect on
HUVEC, acting both as ROS scavengers (they carry
SOD2 and catalase) and inducing the expression of
SOD-1 in these cells [71].
As far as we know, the first evidence that MVs
could be involved in ROS metabolism was the loca-
tion of Cu, Zn superoxide dismutase (SOD2),
a cytosolic enzyme that destroys ROS, in MVs from
neuroblastoma [72]. On the other hand, tumor-
derived MVs and lymphocyte-derived MVs induced
the production of ROS in human monocytes [73]
and endothelial cells [74]. These early studies already
pointed out the different roles and mechanistic pro-
cedures that MVs can maintain with ROS: MVs can
directly scavenge or produce ROS [41] but they can
also act on ROS indirectly, modifying the ROS con-
tent of their target cells (Figure 2).
MVs can carry different antioxidant enzymes
involved in ROS scavenging: GPX, GST, PRDX,
SOD2 or CAT [71,75–78]. Our group recently
found a complete list of antioxidant activities and
related molecules in MVs derived from HUVEC by
proteomic analysis [79]. The fuel that nourishes the
antioxidant machinery is NADPH. We also demon-
strated that HUVEC-derived MVs contain the enzy-
matic machinery necessary to synthesize NADPH
using blood metabolites to feed different biosynthetic
pathways [80]. This last possibility seems to convert
the HUVEC-derived MVs into an autonomous extra-
cellular organelle devoted to scavenging ROS from
blood and maintaining the redox status in plasma.
A protective role of epididymosomes (a type of MV
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originated from epididymal cells) for epididymal
spermatozoa against ROS released by dying cells
has also been suggested [81]. On the other hand,
the existence of NADPH oxidase, an enzyme that
synthesizes ROS, has also been demonstrated in
MVs [66,82]. Taking all this into account, it is
possible to assume that a group of MVs can act as
ROS scavengers in the extracellular compartment,
and others as ROS producers when their content is
incorporated into the target cells. As far as we know,
the possibility that MVs can directly increase ROS in
the extracellular compartment has not been
Figure 2. Schematic drawing showing the main effects of MVs on ROS. At the top, the direct effect of MVs; at the bottom, the
indirect (cell-mediated) effect. The effect of ROS- regulated signaling pathways on the ROS content of the cell is not included.
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demonstrated, although their ability to produce ROS
has been assessed [82].
Although the direct effect of MVs on ROS has been
analyzed in the previous paragraph, MVs, under phy-
siological conditions, can also have an indirect effect,
inducing changes in their target cells that can result in
a compensatory mechanism against the effects of oxi-
dative stress or causing detrimental effects [65]. This
indirect effect can be achieved by (a) the incorporation
to the cells of the enzymatic components included in
MVs involved in ROS production/destruction, or (b)
the incorporation of signaling molecules that can mod-
ify cellular activities and/or gene expression involved in
the regulation of redox processes, which finally affect
the cellular ROS content. The induction of antioxidant
enzyme expression [71,83] and the ROS increase
[74,82,84] have been demonstrated. The precise mole-
cular mechanisms activated by the MVs in the target
cells are not well known. However, NF-κB, JNK or
PI3K/Akt-dependent signaling pathways are usually
involved in ROS production in the target cells
[68,74,84] whereas suppression of NOX expression
[85] or inhibition of NF-κB [86] are molecular
mechanisms used to decrease ROS. A common
response to oxidative stress involves two transcription
factors, Nrf2 and MAFG, as well as the activation of
target genes via antioxidant response elements (AREs)
[87]. As far as we know, however, these transcription
factors have not been found in MVs, although they can
be included in exosomes (see last paragraph).
MicroRNAs (miRNAs) are molecules involved in the
control of oxidative stress [37,88–91] and MVs repre-
sent transport vehicles for these [92]. In particular,
miR-126, as well as miR-21 [93,94], miR-128 [95],
miR-144 [94], miR-34a-5p [96], miR-1915-3p [97]
and miR-638 [98], are all involved in oxidative stress
and have been found in MVs.
Similar results have been reported for MVs derived
from cells subjected to stress or under pathological
conditions. MVs derived from ischemic muscles (56),
plasma of patients with lupus [99] or neutrophils
infected with Mycobacterium tuberculosis [70] were
shown to induce ROS in mononuclear cells, neutro-
phils and macrophages, respectively. However, MVs
derived from cells exposed to ROS induced ROS toler-
ance in PC12 cells [100]. MVs derived from tumour
cells showed a similar behavior; they can contain anti-
oxidant enzymes [72] or can modulate the activity of
human monocytes by increasing ROS, among other
effects [73].
Although MVs produced after a hypoxia/reoxygena-
tion treatment contain ROS and may promote apoptosis
and oxidative stress in the myocardium [101], the use of
MVs as therapeutic tools has been demonstrated.
Treatments with MVs reduced oxidative stress in injured
kidneys [85,102] and in experimental colitis [86]. In
addition, it has been recently demonstrated that MVs
derived from mesenchymal cells downregulate oxidative
stress in osteoarthritic chondrocytes [103] and that those
secreted by genistein (a polyphenol)-treated cells have
a protective effect against oxidative stress [104]. On the
contrary, in cultured glomerular endothelial cells, platelet
microparticles have been shown to induce ROS produc-
tion and may contribute to glomerular endothelial injury
associated with diabetic nephropathy [104].
A question of interest is whether MVs having an antag-
onistic relationship with ROS (scavenging or production)
may (1) coexist in the same place and (2) be produced by
the same cell. Plasma MVs can be a paradigm to respond
to these questions. We have demonstrated that cultured
endothelial cells synthesize MVs that act as ROS scaven-
gers [79,80], but it has also been suggested that MVs
produce ROS as part of the signaling processes in endothe-
lial cells [82]. This raises the possibility that MVs involved
in ROS scavenging and ROS production may be found
simultaneously in plasma, the first ones acting as autono-
mous structures independent of target cells and the second
ones acting on target cells; obviously, both types of MVs
should have specific mechanisms of cargo.
The underlying molecular mechanisms of aging
appear to be related to increased free radical release
[105]; senescence has been equally associated with an
increase of oxidative stress. Two possible mechanisms
may lead to this oxidative status: a malfunctioning of the
antioxidant machinery or an increase of oxidative pro-
cesses by metabolic alterations of the cells. As previously
stated (section 3, first paragraph), senescent cells produce
more MVs probably due to their high ROS levels.
Senescent endothelial cell-derived MVs exhibit an induc-
tive effect of ROS on endothelial cells [62,106]. However,
we have recently demonstrated that senescent HUVEC-
derived MVs have a functional and more developed
antioxidant machinery, suggesting that the increase of
the antioxidant machinery is not able to compensate the
higher production of ROS in senescence [79]. In this
context, a recent study has demonstrated that the culture
time induces changes in microRNAs related to genes
involved in ROS production [107]. On the other hand,
MVs could modify the senescence status, a condition
with high oxidative stress. In this regard, MVs of inter-
leukin-1β-stimulated mesenchymal stem cells have been
demonstrated to downregulate β-galactosidase activity,
a marker of senescence [108].
In spite of their possible separate origin and func-
tions, MVs and exosomes can have common func-
tional mechanisms; for example, exosomes have also
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been involved in ROS metabolism [109]. However, the
actual multivesicular body origin of the small EVs is
not clearly demonstrated, and the functions described
may be contained in exosomes and/or in co-isolated
small MVs [3]. Thus, although this review is mainly
directed at studying the interrelationship between
MVs and ROS, this final paragraph is dedicated to
the relationship between exosomes (and co-isolated
small MVs) and ROS. Enzymes such as NADPH oxi-
dase, involved in ROS production, have been found in
platelet-derived exosomes [110]. In addition, exosomes
carry cytochrome P450 [111], a protein family
involved in ROS generation [112]. In eosinophils, an
increase in ROS production by eosinophil-derived
exosomes has been demonstrated in patients with
asthma [113]. Production of ROS in axonal regenera-
tion induced by macrophage-derived exosomes con-
taining NADPH oxidase has also been recently
demonstrated [114]; in this case, the ROS generated
by NADPH oxidase served as an activator of the Akt-
dependent signaling pathway involved in regeneration.
In the scientific literature, however, it is easier to find
studies pointing towards an antioxidant role of exo-
somes, although this antioxidant role can be carried
out by different mechanisms. Cells treated with exo-
somes derived from stem cells ameliorate their oxida-
tive stress [115] or reduce ROS production [116].
Several studies have demonstrated a protective func-
tion of exosomes against oxidative stress [117,118] as
well as an increase of antioxidants in exosomes
derived from cells treated with ROS, and the subse-
quent induction of antioxidant mechanisms in cells
treated with these exosomes [119,120]. The presence
of Nrf2 mRNA, a transcription factor involved in the
anti-oxidant stress response, and miRNAs involved in
the oxidative stress response has also been demon-
strated in exosomes from granulose cells subjected to
hydrogen peroxide [121]. In addition, exosomes can
diminish cellular oxidative stress by secreting harmful
molecules that can promote ROS elevation and induce
senescence, as has been demonstrated in the case of
nuclear DNA accumulation in the cytoplasm [122].
The interrelationship of ROS and exosomes is phylo-
genetically preserved; the existence of antioxidant
molecules (SOD2, TRX, TRXR and catalase) has also
been demonstrated in exosomes from the yeast,
Cryptococcus neoformans [123].
Conclusions
MVs, or at least a group of them, maintain a close inter-
relationship with ROS and, subsequently, with oxidative
stress. This interrelationship can be described as either
direct or indirect. MVs, by themselves (direct effect), can
act as ROS scavengers, reducing oxidative stress, since
they carry antioxidant enzymes and molecules that form
part of the cellular antioxidant machinery as well as
enzymes involved in ROS production. After interacting
with their target cells (indirect effect or horizontal trans-
fer), MVs can also increase or reduce ROS levels by
transferring enzymatic components or signaling mole-
cules that can modify cell metabolism and/or gene
expression involved in the regulation of redox processes.
This direct and indirect capacity of ROS production or
scavenging by the MVs can be affected by the physiolo-
gical conditions of the cell that produces the MVs. Stress
or pathological conditions, as well as aging or senescence,
also modify the effect of MVs on ROS metabolism. Since
oxidative stress is involved in different pathological con-
ditions and aging, the use of MVs with antioxidant
activity could be a useful strategy to prevent the deleter-
ious effects of ROS. The adaptive response consisting of
modifying the number and content of MVs related with
ROSmetabolism under these circumstances supports this
possibility. Finally, the direct and indirect capacity of
ROS production or scavenging implies the existence of
different types of MVs. The mechanisms that regulate the
synthesis of each type, their mechanisms of cargo and the
mechanism that guides them to fuse with their target
cells or to stay in the extracellular space are all interesting
subjects for future explorations.
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